Structural proteins perform much like their name suggests, they maintain cell shape and make up connective tissues like cartilage and bone. Telling a cell biologist that a structural protein is doubling as a transcription factor will not be believed as it’s never been seen before. Now, researchers at Washington State University, Penn State, the Chinese Academy of Sciences, Zhejiang Sci-Tech University and the University of Texas have discovered that a well known protein ATF5, or Activating Transcription Factor 5, which controls how often specific genes are expressed, is also acting as a structural protein. The opensource study is published in the journal Cell.
Previous studies show that ATF5 regulates genes that control cell survival. The current study identified a part this protein is playing, within the region of the cell called the centrosome, that is not related to its transcription factor role. The researchers note that the discovery provides the first evidence of structural interactions within the centrosome and the role of ATF5, which was strategically located within the centrosome and playing a totally different role than previously understood.
The team explain that the centrosome is the cell component vital to successful cell division and duplication, which affect a wide spectrum of larger processes from healing to cancer growth to fighting off disease. They go on to add that failure of centrosome duplication can result in malformation of mitotic spindles, causing a variety of genomic instabilities. Malformed cells contribute to tumour development and conditions such as dwarfism, ciliopathy, microcephaly and problems with cilia movement, which is why cells observed in the current study included ovary cancer, breast cancer and glioma (brain tumour).
Earlier studies show that cilia work like antenna and communicate with the rest of the cell to move it toward nutrients, however, knowledge is limited as to how cilia work. The data findings helps connect the dots, with the lab hoping this research will expand understanding of cell survival.
In a previous study from the team, ATF5 was tagged a fluorescent protein produced by jellyfish. ATF5 was discovered in an area of the cell that didn’t seem to make sense. Therefore the researchers wanted to show that the presence of ATF5 outside its ‘normal place’ was irrelevant. However, it became apparent it had real purpose and ultimately, became a big discovery.
Source: Washington State University
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.